MolNFT v1 · #135488 · protein
C-terminal ankyrin repeats from human kidney-type glutaminase (kga) - tetragonal crystal form
5U0I · Glutaminase kidney isoform, mitochondrial: “C-terminal ankyrin repeats from human kidney-type glutaminase (kga) - tetragonal crystal form”. X-ray diffraction, 2 ligands (NA, CL). MolNFT v1 #135488 on GenesisL1: 3D structure, binding…
- PDB
- 5U0I
- Type
- protein
- Length
- 183 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Glutaminase kidney isoform, mitochondrial
- EC
- 3.5.1.2
- UniProt
- O94925
- Ligands
- NA, CL
Structure
x-ray diffraction · 2 distinct chains · 57% helix, 0% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Glutaminase kidney isoform, mitochondrial (EC 3.5.1.2) | protein | 90 | 58% helix, 0% strand | O94925 |
| B | Glutaminase kidney isoform, mitochondrial (EC 3.5.1.2) | protein | 93 | 57% helix, 0% strand | O94925 |
Ligands and binding sites
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Interfaces
1 interface between chains.
- A–B · 829 Ų buried · 14 hydrogen bonds · protein-protein
Compared structures
- 5U0I · C-terminal ankyrin repeats from human kidney-type glutaminase (KGA) - tetragonal crystal… · the same entry in another collection · chain A against A, TM-score 1.00
- O94925 · AlphaFold monomer V2.0 prediction for glutaminase kidney isoform, mitochondrial (O94925) · a predicted model of the same protein · chain A against A, TM-score 0.98
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt O94925
- Elsewhere: RCSB PDB 5U0I · PDBe 5U0I · UniProt O94925
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.